U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07813663) titled 'A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JZP269 in Healthy Male and Female Participants' on Sept. 04.
Brief Summary: This study will characterize the safety, tolerability, pharmacokinetics (PK), and pharmacodynamic (PD) of JZP269 in healthy participants.
Study Start Date: Sept. 22
Study Type: INTERVENTIONAL
Condition:
Healthy Participants
Intervention:
DRUG: JZP269
Administered as described.
DRUG: Placebo
Administered as described.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Jazz Pharmaceuticals
Published by HT Digital Content Services with permission from Health Daily ...